MDxHealth SA Price to Free Cash Flow Ratio 2018-2025 | MDXH
Historical price to free cash flow ratio values for MDxHealth SA (MDXH) since 2018.
| MDxHealth SA Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-02-10 | 3.62 | 0.00 | |
| 2025-09-30 | 4.65 | $-0.29 | 0.00 |
| 2025-03-31 | 1.42 | $-0.46 | 0.00 |
| 2024-12-31 | 2.37 | $-0.60 | 0.00 |
| 2024-09-30 | 2.08 | $-0.91 | 0.00 |
| 2024-06-30 | 2.39 | $-0.88 | 0.00 |
| 2024-03-31 | 2.59 | $-0.92 | 0.00 |
| 2023-12-31 | 3.94 | $-0.94 | 0.00 |
| 2023-09-30 | 2.80 | $0.92 | 3.03 |
| 2023-06-30 | 3.41 | $-0.44 | 0.00 |
| 2023-03-31 | 3.24 | $0.33 | 9.86 |
| 2022-12-31 | 6.61 | 0 | 0.00 |
| 2022-09-30 | 6.75 | $-1.53 | 0.00 |
| 2022-06-30 | 8.35 | 0 | 0.00 |
| 2022-03-31 | 8.30 | $-0.56 | 0.00 |
| 2021-12-31 | 9.52 | 0 | 0.00 |
| 2021-06-30 | 0.00 | 0 | 0.00 |
| 2020-12-31 | 0.00 | 0 | 0.00 |
| 2020-06-30 | 0.00 | 0 | 0.00 |
| 2019-12-31 | 0.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.167B | $0.090B |
| MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $33.427B | 38.66 |
| Tempus AI (TEM) | United States | $10.416B | 0.00 |
| Doximity (DOCS) | United States | $7.021B | 28.91 |
| Hims & Hers Health (HIMS) | United States | $6.019B | 48.96 |
| IRhythm Holdings (IRTC) | United States | $5.017B | 0.00 |
| Privia Health (PRVA) | United States | $2.879B | 180.08 |
| Hinge Health (HNGE) | United States | $2.773B | 0.00 |
| 10x Genomics (TXG) | United States | $2.525B | 0.00 |
| Heartflow (HTFL) | United States | $2.451B | 0.00 |
| Omnicell (OMCL) | United States | $2.185B | 44.68 |
| Inspire Medical Systems (INSP) | United States | $2.134B | 35.31 |
| Azenta (AZTA) | United States | $1.726B | 70.81 |
| Enovis (ENOV) | United States | $1.268B | 6.66 |
| Clover Health Investments (CLOV) | United States | $1.137B | 0.00 |
| Schrodinger (SDGR) | United States | $1.038B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.965B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.807B | 0.00 |
| Phreesia (PHR) | United States | $0.796B | 0.00 |
| Talkspace (TALK) | United States | $0.683B | 137.33 |
| Standard BioTools (LAB) | United States | $0.542B | 0.00 |
| Claritev (CTEV) | United States | $0.459B | 0.00 |
| Evolent Health (EVH) | United States | $0.364B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.362B | 0.00 |
| Carlsmed (CARL) | United States | $0.331B | 0.00 |
| TruBridge (TBRG) | United States | $0.307B | 14.09 |
| Senseonics Holdings (SENS) | United States | $0.296B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.264B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.261B | 0.00 |
| CapsoVision (CV) | United States | $0.256B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.197B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| CareCloud (CCLD) | United States | $0.114B | 6.28 |
| Outset Medical (OM) | United States | $0.090B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| Pulmonx (LUNG) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.050B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.018B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| Zhongchao (ZCMD) | China | $0.011B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.011B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |